Catherine (Choy) Smith, MD, Oncology, San Francisco, CA, UCSF Medical Center

CatherineC(Choy)SmithMD

Oncology San Francisco, CA

Hematologic Oncology

Assistant Professor, Medicine, UCSF School of Medicine

Dr. Smith is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Smith's full profile

Already have an account?

Education & Training

  • UCSF
    UCSFFellowship, Hematology/Oncology, 2006 - 2009
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2005
  • Duke University School of Medicine
    Duke University School of MedicineClass of 2002

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2005 - 2023
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Combined Single-Cell DNA Genotyping and Protein Quantification (DAb-seq) in Acute Myeloid Leukemias Reveals Distinct Immunophenotypic Subsets Among Pathogenic Clones
    Catherine C. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Single Cell Sequencing Reveals Evolution of Tumor Heterogeneity of Acute Myeloid Leukemia on Quizartinib
    Catherine C. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative Neoplasms
    Catherine C. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Therapy of Acute Myeloid Leukemia: Adapting to Change 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Astellas Presents New Data on XOSPATA® (Gilteritinib) in FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia at the 2019 American Society of Hematology Annual Meeting
    Astellas Presents New Data on XOSPATA® (Gilteritinib) in FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia at the 2019 American Society of Hematology Annual MeetingDecember 2nd, 2019

Hospital Affiliations